Alves, C. L., Ehmsen, S., Terp, M. G., Portman, N., Tuttolomondo, M., Gammelgaard, O. L., . . . Ditzel, H. J. (2021). Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer. Nature Communications, 12(1), 1-15. https://doi.org/10.1038/s41467-021-25422-9

Alves, Carla L., et al. "Co-targeting CDK4/6 and AKT with Endocrine Therapy Prevents Progression in CDK4/6 Inhibitor and Endocrine Therapy-resistant Breast Cancer." Nature Communications 12, no. 1 (2021): 1-15. https://doi.org/10.1038/s41467-021-25422-9.

Alves, Carla L., et al. "Co-targeting CDK4/6 and AKT with Endocrine Therapy Prevents Progression in CDK4/6 Inhibitor and Endocrine Therapy-resistant Breast Cancer." Nature Communications, vol. 12, no. 1, 2021, pp. 1-15, https://doi.org/10.1038/s41467-021-25422-9.